Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Argentinian (MERVAL) Pharma Industry Analysis

UpdatedAug 16, 2026
DataAggregated Company Financials
Companies1
  • 7D1.3%
  • 3M-2.2%
  • 1Y21.0%
  • YTDn/a

In the last week, Pharma has been flat. As for the the longer term, the industry is up 15% over the past 12 months.

Industry Valuation and Performance

Has the Argentinian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 16 Aug 2026AR$125.6bAR$114.0bAR$13.0b9.6x9.6x1.1x
Tue, 14 Jul 2026AR$127.6bAR$119.6bAR$16.1b7.8x7.9x1.1x
Thu, 11 Jun 2026AR$128.4bAR$119.6bAR$16.1b8x8x1.1x
Sat, 09 May 2026AR$130.0bAR$126.7bAR$2.4b54.7x54.1x1x
Mon, 06 Apr 2026AR$143.2bAR$130.8b-AR$1,946,644,487.0056.6x-73.6x1.1x
Wed, 04 Mar 2026AR$144.6bAR$107.5b-AR$10,024,883,532.00n/a-14.4x1.3x
Fri, 30 Jan 2026AR$166.0bAR$107.5b-AR$10,024,883,532.00n/a-16.6x1.5x
Sun, 28 Dec 2025AR$168.3bAR$108.5b-AR$8,970,776,885.00n/a-18.8x1.6x
Tue, 25 Nov 2025AR$156.9bAR$108.5b-AR$8,970,776,885.00n/a-17.5x1.4x
Thu, 23 Oct 2025AR$100.9bAR$103.2bAR$8.2b8x12.2x1x
Sat, 20 Sep 2025AR$84.9bAR$104.5bAR$9.0b6.8x9.4x0.8x
Mon, 18 Aug 2025AR$112.1bAR$104.5bAR$9.0b9x12.4x1.1x
Wed, 16 Jul 2025AR$122.3bAR$102.7bAR$16.3b6x7.5x1.2x
Fri, 13 Jun 2025AR$129.1bAR$104.7bAR$17.4b6.1x7.4x1.2x
Sun, 11 May 2025AR$119.0bAR$100.1bAR$22.4b4.8x5.3x1.2x
Tue, 08 Apr 2025AR$128.1bAR$97.1bAR$23.7b4.9x5.4x1.3x
Thu, 06 Mar 2025AR$140.0bAR$42.6bAR$18.2b6.5x7.7x3.3x
Sat, 01 Feb 2025AR$139.8bAR$42.6bAR$18.2b6.3x7.7x3.3x
Mon, 30 Dec 2024AR$142.6bAR$42.6bAR$18.2b6.6x7.8x3.3x
Wed, 27 Nov 2024AR$154.1bAR$42.6bAR$18.2b6.6x8.5x3.6x
Fri, 25 Oct 2024AR$101.4bAR$40.7bAR$4.6b16.4x22.3x2.5x
Sun, 22 Sep 2024AR$77.6bAR$40.7bAR$4.6b12.8x17x1.9x
Tue, 20 Aug 2024AR$85.6bAR$52.7bAR$2.3b34.8x37.9x1.6x
Thu, 18 Jul 2024AR$77.3bAR$41.1b-AR$3,264,658,797.004.5x-23.7x1.9x
Sat, 15 Jun 2024AR$86.1bAR$41.1b-AR$3,264,658,797.004.9x-26.4x2.1x
Mon, 13 May 2024AR$77.3bAR$43.6b-AR$10,287,966,966.009.2x-7.5x1.8x
Wed, 10 Apr 2024AR$79.1bAR$40.2b-AR$10,767,928,257.0054.9x-7.3x2x
Fri, 08 Mar 2024AR$68.1bAR$9.6b-AR$4,702,241,388.0045.2x-14.5x7.1x
Sun, 04 Feb 2024AR$96.6bAR$10.3b-AR$4,704,193,685.0058.1x-20.5x9.3x
Tue, 02 Jan 2024AR$59.1bAR$10.3b-AR$4,704,193,685.0033.6x-12.6x5.7x
Thu, 30 Nov 2023AR$58.9bAR$10.3b-AR$4,704,193,685.0030.7x-12.5x5.7x
Sat, 28 Oct 2023AR$58.0bAR$13.0b-AR$2,496,856,221.00n/a-23.2x4.4x
Mon, 25 Sep 2023AR$43.0bAR$13.0b-AR$2,496,856,221.00n/a-17.2x3.3x
Wed, 23 Aug 2023AR$48.7bAR$18.8b-AR$150,001,147.0015.4x-325x2.6x
Price to Earnings Ratio

-325x


Total Market Cap: AR$48.7bTotal Earnings: -AR$150,001,147.00Total Revenue: AR$18.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Argentinian Pharma Industry Price to Earnings3Y Average -11.4x202420252026
Current Industry PE
    There is only one company in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • Total earnings for the Pharmaceuticals industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 88% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Comparison

How does Argentinian Pharma compare with similar industries?

AR Market-2.77%
Healthcare1.30%
Pharma1.30%
Pharma1.30%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RICH Laboratorios RichmondC.I.FAR$1.56k1.3%
+AR$1.6b		21.0%PE9.6x

Latest News

ROSE
AR$156.00
Instituto Rosenbusch
7D
-1.6%
1Y
-20.2%
RICH
AR$1,555.00
Laboratorios RichmondC.I.F
7D
1.3%
1Y
21.0%